A Rapid Method for Screening Vaccinia Virus Recombinants
Overview
Biotechnology
Affiliations
A rapid and small-scale method for screening vaccinia virus recombinants employing micrococcal nuclease is described. This protocol utilizes the differential sensitivity of cellular and viral DNA to the nuclease, which can be selectively activated by addition of Ca2+ and inactivated by elimination of Ca2+. Two to five micrograms of viral DNA can be obtained from one infected L cell plate (50 mm) after overnight incubation.
Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
OConnell C, Jasperse B, Hagen C, Titong A, Verardi P PLoS One. 2020; 15(4):e0230711.
PMID: 32240193 PMC: 7117657. DOI: 10.1371/journal.pone.0230711.
IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.
Verardi P, Legrand F, Chan K, Peng Y, Jones L, Yilma T J Interferon Cytokine Res. 2013; 34(3):169-78.
PMID: 24168450 PMC: 3942681. DOI: 10.1089/jir.2013.0052.
Wang Z, Martinez J, Zhou W, La Rosa C, Srivastava T, Dasgupta A Vaccine. 2009; 28(6):1547-57.
PMID: 19969118 PMC: 2821965. DOI: 10.1016/j.vaccine.2009.11.056.
Legrand F, Verardi P, Chan K, Peng Y, Jones L, Yilma T Proc Natl Acad Sci U S A. 2005; 102(8):2940-5.
PMID: 15705716 PMC: 548597. DOI: 10.1073/pnas.0409846102.
Legrand F, Verardi P, Jones L, Chan K, Peng Y, Yilma T J Virol. 2004; 78(6):2770-9.
PMID: 14990697 PMC: 353749. DOI: 10.1128/jvi.78.6.2770-2779.2004.